rh-0345 has been researched along with tryptamine in 1 studies
Studies (rh-0345) | Trials (rh-0345) | Recent Studies (post-2010) (rh-0345) | Studies (tryptamine) | Trials (tryptamine) | Recent Studies (post-2010) (tryptamine) |
---|---|---|---|---|---|
29 | 0 | 9 | 844 | 2 | 221 |
Protein | Taxonomy | rh-0345 (IC50) | tryptamine (IC50) |
---|---|---|---|
Vif | Human immunodeficiency virus 1 | 1.66 | |
Tat | Human immunodeficiency virus 1 | 11.753 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 1.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
1 other study(ies) available for rh-0345 and tryptamine
Article | Year |
---|---|
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |